BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 16/02/2018

FDA Announces Guidance for Developing Prescription Drugs for Acute Migraine Treatment

The Food and Drug Administration (FDA) has released a guidance document to help pharmaceutical companies develop prescription medications for treating acute migraines, finalizing a draft issued in 2014.

Source: Federal Register — Food and Drug AdministrationOpen original release →